How the documents count abdominal pain
US Table 1 keeps to reactions reported by 5% or more of the Trulicity® groups and more often than on placebo, pooled from trials in which 1,670 adults took a fixed 0.75 mg or 1.5 mg dose and 568 took placebo. [1] Its abdominal pain row is a composite: a footnote folds in abdominal discomfort, abdominal pain, lower and upper abdominal pain, abdominal tenderness and gastrointestinal pain. [1] Canada uses the same composite, prints head counts and records events whatever their cause, so its figures mix drug effects with pain that would have happened anyway. [4] In the EU table, abdominal pain carries a dagger meaning that 0.75 mg sits one frequency class below 1.5 mg. [3]
| Source and study pool | Placebo or comparator | Trulicity® 0.75 mg | Trulicity® 1.5 mg |
|---|---|---|---|
| US Table 1, placebo-controlled pool, composite term [1] | 4.9% | 6.5% | 9.4% |
| Canada Table 2, placebo-controlled, 26 weeks [4] | 28 of 568 (4.9%) | 54 of 836 (6.5%) | 78 of 834 (9.4%) |
| Canada Table 2, all studies up to 104 weeks [4] | All comparators: 105 of 1,844 (5.7%) | 123 of 1,671 (7.4%) | 171 of 1,671 (10.2%) |
| EU SmPC section 4.8, frequency class [3] | — | Common (1 in 100 to 1 in 10) | Very common (more than 1 in 10) |
| US Table 2, 1.5 mg / 3 mg / 4.5 mg dose trial [1] | No placebo arm | — | Not listed (under 5% in every group) |
| Severe gastrointestinal reactions, US section 5.6 [1] | 1.4% | 2.2% | 4.3% |
How large is the extra risk?
Nearly one person in twenty on placebo reported abdominal pain, so a fair share of what people on Trulicity® reported would probably have happened without it. [1] The excess over placebo was about 1.6 percentage points on 0.75 mg and 4.5 points on 1.5 mg, a gap that widened with dose. [1] The longer Canadian pool points the same way against active treatments, at 10.2% on 1.5 mg against 5.7%. [4]
Severe stomach and bowel reactions as a whole, not just pain, affected 2.2% on 0.75 mg and 4.3% on 1.5 mg, against 1.4% on placebo, and the label does not recommend Trulicity® for people with severe gastroparesis. [1] Pain occasionally led people to stop. In a 24-week trial adding dulaglutide to an SGLT2 inhibitor, two people on 1.5 mg withdrew because of abdominal pain, and in a 28-week trial with basal insulin, abdominal discomfort led 0.7% on Trulicity® to stop, against none on placebo. [4]
A safety-database view
A 2022 study of US FDA adverse event reports from 2018 to 2022 compared five GLP-1 medicines. Upper abdominal pain was most disproportionately reported with liraglutide, and dulaglutide had the lowest share of gut reports classed as severe, 12.29%, against 23.31% for liraglutide; most gut events were reported within the first month of use. [8] Reporting databases depend on who chooses to report, so they cannot give a rate or prove cause; this is a pattern in reports, not proof that one medicine is gentler.
For scale, a 2025 review in Mayo Clinic Proceedings estimates that 40% to 70% of people on GLP-1 or GLP-1/GIP medicines have some digestive side effect, which is why mild abdominal pain is so often part of the picture. [9]
Reasons the belly may hurt on Trulicity®
- Supported by the label: abdominal pain is one of the gut reactions reported more often on Trulicity® than on placebo, and more often on the higher dose. [1] The label also says dulaglutide slows stomach emptying; our Trulicity® nausea page has the details. [1]
- Plausible, not measured as a cause of pain: constipation, gas and indigestion are all more frequent on Trulicity®, and MedlinePlus notes that cramp-like pain is usually due to gas and bloating. [1][5] No trial has worked out how much of the pain row these explain.
- General medical knowledge: MedlinePlus separates generalised pain, typical of indigestion, gas or a stomach virus, from pain in one spot, which more often points to an organ such as the appendix, gallbladder or stomach, and from colicky pain that comes in waves, often from gallstones or kidney stones. [5]
Where it hurts, and what that can mean
Pancreatitis: the Medication Guide describes intense belly pain that persists, whether or not nausea or vomiting come with it, and that may be felt as far as the back; it asks you to stop Trulicity® and call your provider right away. [2] MedlinePlus’s dulaglutide page places that pain in the upper left or middle of the abdomen. [7] Rates and trial data are on our Trulicity® pancreatitis page.
Gallbladder: the Medication Guide links gallbladder problems to pain in the upper stomach together with yellowing of the skin or eyes, fever or clay-coloured stools, and asks you to contact your provider right away if they appear. [2] Cleveland Clinic notes that upper right pain often involves the liver or gallbladder, while upper left pain can come from the pancreas, an inflamed stomach lining or an ulcer. [6] Our Trulicity® gallbladder page covers the trial findings.
Bowel blockage: pain with a swollen belly, vomiting, or no stool or gas passing can mean the bowel has stopped moving, something reported rarely after approval; the detail sits on our Trulicity® constipation page. [1][3]
Location is a clue, not a diagnosis. MedlinePlus stresses that the strength of pain does not always match the seriousness of its cause: gas or a stomach virus can hurt a great deal, while early appendicitis may cause only mild pain. [5]
Causes that have nothing to do with dulaglutide
MedlinePlus lists many causes of abdominal pain unrelated to medicines: irritable bowel syndrome, food intolerance such as lactose intolerance, heartburn and reflux, urinary tract infections, diverticulitis, inflammatory bowel disease, a trapped hernia, kidney stones, menstrual cramps, ectopic pregnancy and, less often, reduced blood supply to the bowel, an abdominal aortic aneurysm or cancer. [5] Cleveland Clinic adds that pain felt in the belly can come from outside the digestive system altogether, for instance from the pelvic organs. [6]
Because so many of these overlap with ordinary Trulicity® side effects, a new kind of pain, a different location or pain that started before the first injection deserves its own assessment rather than being put down to the medicine. [6]
Easing mild pain: what the sources describe
For mild abdominal pain, MedlinePlus describes sipping water or other clear fluids, holding off solid food for the first few hours and, after vomiting, returning to small amounts of mild food. It also reminds people with diabetes to check their blood sugar more often while unwell. [5] If the pain sits high in the abdomen after meals and feels like heartburn, it says antacids may help, and suggests avoiding citrus, high-fat or fried food, tomato products, caffeine, alcohol and fizzy drinks. [5] It also says no medicine should be taken for the pain without speaking to a provider, so ask your pharmacist or prescriber before reaching for a painkiller. [5]
To prevent some kinds of pain, MedlinePlus lists drinking enough water, eating smaller meals more often, regular exercise and limiting foods that cause gas. [5] Saha and colleagues likewise put diet first when GLP-1 treatment upsets the gut: eating little and often, drinking enough and cutting back on fatty or sugary food. [9]
Trulicity® is a registered trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.
When to get help
The signs and contact information below come from this article’s sourced guidance.
Emergency
- Severe stomach pain that will not go away, with or without vomiting, sometimes felt through to the back
Contact: Stop Trulicity® and call your prescriber right away
- Sudden, sharp belly pain, a rigid belly that is hard to the touch, chest, neck or shoulder pain, or pain between the shoulder blades with nausea
Contact: Emergency services (911 / 112)
MedlinePlus [5]
- Pain with vomited blood or blood in the stool, or no stool passing, especially with vomiting
Contact: Emergency services (911 / 112)
MedlinePlus [5]